vs

Side-by-side financial comparison of Home Federal Bancorp, Inc. of Louisiana (HFBL) and IMMUCELL CORP (ICCC). Click either name above to swap in a different company.

Home Federal Bancorp, Inc. of Louisiana is the larger business by last-quarter revenue ($6.0M vs $5.5M, roughly 1.1× IMMUCELL CORP). Home Federal Bancorp, Inc. of Louisiana runs the higher net margin — 27.8% vs -2.5%, a 30.4% gap on every dollar of revenue. On growth, Home Federal Bancorp, Inc. of Louisiana posted the faster year-over-year revenue change (18.2% vs -8.4%). Over the past eight quarters, Home Federal Bancorp, Inc. of Louisiana's revenue compounded faster (10.7% CAGR vs 3.9%).

Home Federal Bancorp, Inc. of Louisiana is a U.S. bank holding company based in Louisiana. It operates community banking services via its subsidiary, offering retail customers and local small businesses a full suite of financial products including deposit accounts, consumer loans, mortgage loans, and commercial financing, primarily serving local markets across Louisiana.

ImmuCell Corp is a US-based animal health biotechnology company that develops, manufactures and markets innovative products for livestock, primarily dairy cattle. Its core offerings include preventive and therapeutic solutions for common bovine health issues such as mastitis, serving agricultural producers and veterinary providers across North America.

HFBL vs ICCC — Head-to-Head

Bigger by revenue
HFBL
HFBL
1.1× larger
HFBL
$6.0M
$5.5M
ICCC
Growing faster (revenue YoY)
HFBL
HFBL
+26.6% gap
HFBL
18.2%
-8.4%
ICCC
Higher net margin
HFBL
HFBL
30.4% more per $
HFBL
27.8%
-2.5%
ICCC
Faster 2-yr revenue CAGR
HFBL
HFBL
Annualised
HFBL
10.7%
3.9%
ICCC

Income Statement — Q2 FY2026 vs Q3 FY2025

Metric
HFBL
HFBL
ICCC
ICCC
Revenue
$6.0M
$5.5M
Net Profit
$1.7M
$-139.7K
Gross Margin
42.9%
Operating Margin
35.1%
0.4%
Net Margin
27.8%
-2.5%
Revenue YoY
18.2%
-8.4%
Net Profit YoY
64.2%
80.1%
EPS (diluted)
$0.54
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HFBL
HFBL
ICCC
ICCC
Q4 25
$6.0M
Q3 25
$5.9M
$5.5M
Q2 25
$5.6M
$6.4M
Q1 25
$5.2M
$8.1M
Q4 24
$5.1M
$7.8M
Q3 24
$4.7M
$6.0M
Q2 24
$4.9M
$5.5M
Q1 24
$4.9M
$7.3M
Net Profit
HFBL
HFBL
ICCC
ICCC
Q4 25
$1.7M
Q3 25
$1.6M
$-139.7K
Q2 25
$1.2M
$501.9K
Q1 25
$748.0K
$1.4M
Q4 24
$1.0M
Q3 24
$941.0K
$-701.7K
Q2 24
$638.0K
$-1.5M
Q1 24
$732.0K
$-437.9K
Gross Margin
HFBL
HFBL
ICCC
ICCC
Q4 25
Q3 25
42.9%
Q2 25
43.7%
Q1 25
41.6%
Q4 24
36.5%
Q3 24
26.3%
Q2 24
22.5%
Q1 24
31.6%
Operating Margin
HFBL
HFBL
ICCC
ICCC
Q4 25
35.1%
Q3 25
34.1%
0.4%
Q2 25
27.5%
8.8%
Q1 25
18.3%
13.9%
Q4 24
23.7%
8.0%
Q3 24
19.9%
-9.6%
Q2 24
16.9%
-25.3%
Q1 24
18.5%
-4.1%
Net Margin
HFBL
HFBL
ICCC
ICCC
Q4 25
27.8%
Q3 25
27.1%
-2.5%
Q2 25
20.9%
7.8%
Q1 25
14.4%
17.9%
Q4 24
20.0%
Q3 24
19.9%
-11.7%
Q2 24
13.1%
-28.0%
Q1 24
14.9%
-6.0%
EPS (diluted)
HFBL
HFBL
ICCC
ICCC
Q4 25
$0.54
Q3 25
$0.52
$-0.02
Q2 25
$0.38
$0.06
Q1 25
$0.24
$0.16
Q4 24
$0.33
$0.09
Q3 24
$0.31
$-0.09
Q2 24
$0.21
$-0.20
Q1 24
$0.24
$-0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HFBL
HFBL
ICCC
ICCC
Cash + ST InvestmentsLiquidity on hand
$3.9M
Total DebtLower is stronger
$9.5M
Stockholders' EquityBook value
$57.7M
$29.8M
Total Assets
$621.4M
$45.7M
Debt / EquityLower = less leverage
0.32×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HFBL
HFBL
ICCC
ICCC
Q4 25
Q3 25
$3.9M
Q2 25
Q1 25
Q4 24
$3.8M
Q3 24
Q2 24
$1.3M
Q1 24
$960.3K
Total Debt
HFBL
HFBL
ICCC
ICCC
Q4 25
Q3 25
$9.5M
Q2 25
Q1 25
$8.7M
Q4 24
$9.0M
Q3 24
$9.4M
Q2 24
$9.8M
Q1 24
$10.2M
Stockholders' Equity
HFBL
HFBL
ICCC
ICCC
Q4 25
$57.7M
Q3 25
$56.6M
$29.8M
Q2 25
$55.2M
$29.9M
Q1 25
$54.7M
$29.0M
Q4 24
$53.9M
$27.5M
Q3 24
$54.3M
$26.4M
Q2 24
$52.8M
$23.5M
Q1 24
$52.5M
$24.6M
Total Assets
HFBL
HFBL
ICCC
ICCC
Q4 25
$621.4M
Q3 25
$622.6M
$45.7M
Q2 25
$609.5M
$46.7M
Q1 25
$619.6M
$45.6M
Q4 24
$607.8M
$45.1M
Q3 24
$628.4M
$44.4M
Q2 24
$637.5M
$41.9M
Q1 24
$643.0M
$43.1M
Debt / Equity
HFBL
HFBL
ICCC
ICCC
Q4 25
Q3 25
0.32×
Q2 25
Q1 25
0.30×
Q4 24
0.33×
Q3 24
0.36×
Q2 24
0.42×
Q1 24
0.41×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HFBL
HFBL
ICCC
ICCC
Operating Cash FlowLast quarter
$2.9M
$-1.2M
Free Cash FlowOCF − Capex
$-1.8M
FCF MarginFCF / Revenue
-32.3%
Capex IntensityCapex / Revenue
10.8%
Cash ConversionOCF / Net Profit
1.70×
TTM Free Cash FlowTrailing 4 quarters
$715.4K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HFBL
HFBL
ICCC
ICCC
Q4 25
$2.9M
Q3 25
$2.8M
$-1.2M
Q2 25
$5.5M
$1.6M
Q1 25
$991.0K
$1.6M
Q4 24
$2.6M
$-3.1K
Q3 24
$871.0K
$-639.3K
Q2 24
$2.3M
$581.8K
Q1 24
$650.0K
$418.5K
Free Cash Flow
HFBL
HFBL
ICCC
ICCC
Q4 25
Q3 25
$-1.8M
Q2 25
$1.4M
Q1 25
$1.2M
Q4 24
$-199.3K
Q3 24
$843.0K
$-727.7K
Q2 24
$2.3M
$471.0K
Q1 24
$348.1K
FCF Margin
HFBL
HFBL
ICCC
ICCC
Q4 25
Q3 25
-32.3%
Q2 25
22.4%
Q1 25
15.4%
Q4 24
-2.6%
Q3 24
17.8%
-12.1%
Q2 24
46.8%
8.6%
Q1 24
4.8%
Capex Intensity
HFBL
HFBL
ICCC
ICCC
Q4 25
Q3 25
10.8%
Q2 25
2.4%
Q1 25
4.1%
Q4 24
2.5%
Q3 24
0.6%
1.5%
Q2 24
0.8%
2.0%
Q1 24
1.0%
Cash Conversion
HFBL
HFBL
ICCC
ICCC
Q4 25
1.70×
Q3 25
1.74×
Q2 25
4.64×
3.19×
Q1 25
1.32×
1.09×
Q4 24
2.54×
Q3 24
0.93×
Q2 24
3.63×
Q1 24
0.89×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons